1-(4-Methoxy-benzenesulfonyl)-piperidine-4-carboxylic acid, 1g

4-Chloro-3,5-dimethyl-1H-pyrazole, 95.0%, 5g

4-(6-Fluoropyridin-3-yl)-6-(2-hydroxy-2-methylpropoxy)pyrazolo[1,5-a]pyridine-3-carbonitrile, 98%, 1g

N-(3-(5-Bromo-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide, 98%, 100mg

Ácido etilendiaminotetraacético, mínimo 99%, 250 g, envase de plástico.

2-pyrazin-2-yl-1,3-thiazole-4-carboxylic acid, 95.0%, 500mg

N-(8-Amino-6-fluoro-5-methyl-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)acetamide, 97%, 25g

(7S,8aR)-Octahydropyrrolo[1,2-a]piperazin-7-ol dihydrochloride, 97%, 5g

1-(4-Chlorophenyl)biguanide hydrochloride, 97.0%, 25g

Methyl 4-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 97%, 5g

3,5-Bis(trifluoromethyl)-benzeneethanamine, 97.0%, 1g

7-Azaspiro[3.5]nonan-2-one hydrochloride, 95.0%, 10g

2-Butyl-1,3-diazaspiro[4.4]non-1-en-4-one Hydrochloride>98.0%(HPLC)(T)25g